NCT02793544 · OUTCOME
Donor Chimerism
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- MEDIAN
- Unit
- percentage of donor chimerism
- Interval / dispersion
- Full Range
- Time frame
- 28 days, 56 days, 100 days, 180 days, and 365 days post-transplant
What was measured
Peripheral blood chimerism (% of donor chimerism) in whole blood (unsorted). The degree of donor chimerism will be summarized using descriptive statistics.
Groups in this outcome
Myeloablative Conditioning (MAC)
Participants received one of three regimens: cyclophosphamide and total body irradiation; busulfan and cyclophosphamide; or fludarabine and busulfan
Reduced Intensity Conditioning (RIC)
Participants received one of two regimens: fludarabine, cyclophosphamide, and low-dose total body irradiation
| Group | Source count |
|---|---|
| Myeloablative Conditioning (MAC) | 34 |
| Reduced Intensity Conditioning (RIC) | 39 |
Reported measurements
28 days
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Myeloablative Conditioning (MAC) | 100 | Not reported | 92 | 100 | Not reported |
| Reduced Intensity Conditioning (RIC) | 99.1 | Not reported | 0 | 100 | Not reported |
56 days
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Myeloablative Conditioning (MAC) | 100 | Not reported | 64 | 100 | Not reported |
| Reduced Intensity Conditioning (RIC) | 100 | Not reported | 0 | 100 | Not reported |
100 days
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Myeloablative Conditioning (MAC) | 100 | Not reported | 43 | 100 | Not reported |
| Reduced Intensity Conditioning (RIC) | 100 | Not reported | 0 | 100 | Not reported |
180 days
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Myeloablative Conditioning (MAC) | 100 | Not reported | 54.2 | 100 | Not reported |
| Reduced Intensity Conditioning (RIC) | 100 | Not reported | 43.9 | 100 | Not reported |
365 days
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Myeloablative Conditioning (MAC) | 100 | Not reported | 79.4 | 100 | Not reported |
| Reduced Intensity Conditioning (RIC) | 100 | Not reported | 83.2 | 100 | Not reported |
Complete source fields
- classes
- categories
- measurements
- group Id
- OG000
- lower Limit
- 92
- upper Limit
- 100
- value
- 100
- group Id
- OG001
- lower Limit
- 0
- upper Limit
- 100
- value
- 99.1
- title
- 28 days
- categories
- measurements
- group Id
- OG000
- lower Limit
- 64
- upper Limit
- 100
- value
- 100
- group Id
- OG001
- lower Limit
- 0
- upper Limit
- 100
- value
- 100
- title
- 56 days
- categories
- measurements
- group Id
- OG000
- lower Limit
- 43
- upper Limit
- 100
- value
- 100
- group Id
- OG001
- lower Limit
- 0
- upper Limit
- 100
- value
- 100
- title
- 100 days
- categories
- measurements
- group Id
- OG000
- lower Limit
- 54.2
- upper Limit
- 100
- value
- 100
- group Id
- OG001
- lower Limit
- 43.9
- upper Limit
- 100
- value
- 100
- title
- 180 days
- categories
- measurements
- group Id
- OG000
- lower Limit
- 79.4
- upper Limit
- 100
- value
- 100
- group Id
- OG001
- lower Limit
- 83.2
- upper Limit
- 100
- value
- 100
- title
- 365 days
- denoms
- counts
- group Id
- OG000
- value
- 34
- group Id
- OG001
- value
- 39
- units
- Participants
- description
- Peripheral blood chimerism (% of donor chimerism) in whole blood (unsorted). The degree of donor chimerism will be summarized using descriptive statistics.
- dispersion Type
- Full Range
- groups
- description
- Participants received one of three regimens: cyclophosphamide and total body irradiation; busulfan and cyclophosphamide; or fludarabine and busulfan
- id
- OG000
- title
- Myeloablative Conditioning (MAC)
- description
- Participants received one of two regimens: fludarabine, cyclophosphamide, and low-dose total body irradiation
- id
- OG001
- title
- Reduced Intensity Conditioning (RIC)
- param Type
- MEDIAN
- reporting Status
- POSTED
- time Frame
- 28 days, 56 days, 100 days, 180 days, and 365 days post-transplant
- title
- Donor Chimerism
- type
- SECONDARY
- unit Of Measure
- percentage of donor chimerism
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle